Kerlone and interstitial lung disease Patient Reports February 11, 2012

Kerlone Side Effects Report #4703215-8
Kerlone side effect was reported by a Consumer or non-health professional from on June 10, 2005. Female patient, 74 years of age, weighting 176.4 lb, was diagnosed with hypertension, essential hypertension and was treated with Kerlone. After drug was administered, patient experienced the following side effects: dyspnoea, hypocapnia, hypoxia, interstitial lung disease. Kerlone dosage: unknown. During the same period patient was treated with COTAREG, FLECAINE. Patient was hospitalized. Patient recovered.

Kerlone Side Effects Report #4585403-7
Kerlone side effect was reported by a Physician from on Jan 26, 2005. Male patient, 80 years of age, was diagnosed with cardiac failure chronic and was treated with Kerlone. After drug was administered, patient experienced the following side effects: acute prerenal failure, dehydration, hyperuricaemia, interstitial lung disease. Kerlone dosage: 2.5 MG PO. During the same period patient was treated with DIGOXIN, BAYASPIRIN, WARFARIN, DIART. Patient was hospitalized. Patient recovered.

Kerlone Side Effects Report #4551883-6
Kerlone side effect was reported by a Consumer or non-health professional from on Dec 24, 2004. Male patient was diagnosed with cardiac failure chronic and was treated with Kerlone. After drug was administered, patient experienced the following side effects: dyspnoea exertional, eosinophil count increased, interstitial lung disease. Kerlone dosage: 2.5 MG. During the same period patient was treated with BAYASPIRIN, WARFARIN, DIGOXIN, DIART. Patient was hospitalized. Patient recovered.

Kerlone Side Effects Report #4694435-X
Kerlone side effect was reported by a Consumer or non-health professional from on June 10, 2005. Female patient, 74 years of age, weighting 176.4 lb, was diagnosed with cardiac failure, essential hypertension and was treated with Kerlone. After drug was administered, patient experienced the following side effects: dyspnoea, hypocapnia, hypoxia, interstitial lung disease. Kerlone dosage: unknown. During the same period patient was treated with COTAREG, FLECAINE. Patient was hospitalized. Patient recovered.